106 related articles for article (PubMed ID: 198298)
1. Determination of antigen content and effectiveness of foor-and-mouth disease vaccines.
Czelleng F; Sólyom F
Dev Biol Stand; 1976; 35():295-6. PubMed ID: 198298
[TBL] [Abstract][Full Text] [Related]
2. Attempts at potency testing of foot-and-mouth disease vaccines by evaluation of the complement fixing capacity of eluates.
Bauer K
Dev Biol Stand; 1976; 35():297-300. PubMed ID: 198299
[TBL] [Abstract][Full Text] [Related]
3. An evalutation of some methods of assay of foot-and-mouth disease antigen for vaccines.
Garland AJ; Mowat GN; Fletton B
Dev Biol Stand; 1976; 35():323-32. PubMed ID: 198302
[TBL] [Abstract][Full Text] [Related]
4. Studies on the correct quantitative relations of antigen components in mono-, bi- and trivalent foot-and-mouth disease vaccine preparations.
Sólyom F; Czelleng F
Dev Biol Stand; 1976; 35():289-94. PubMed ID: 198297
[TBL] [Abstract][Full Text] [Related]
5. Comparison of laboratory techniques for the evaluation of the antigenic potency of foot-and-mouth disease virus cultures and vaccines.
Terpstra C; Frenkel S; Straver PJ; Barteling SJ; van Bekkum JG
Dev Biol Stand; 1976; 35():333-42. PubMed ID: 198304
[No Abstract] [Full Text] [Related]
6. [Study of the indirect complement fixation test for use in the differentiation of foot-and-mouth disease viruses and the determination of immunity].
Tekerlekov P; Mitev G; Nikolova E
Vet Med Nauki; 1975; 12(6):28-34. PubMed ID: 179191
[TBL] [Abstract][Full Text] [Related]
7. [Development of a method for the quantitative determination of the immunizing antigen (140S) of the foot-and-mouth disease virus].
Tekerlekov P; Vasileva L; Nikolova E; Veleva E
Vet Med Nauki; 1985; 22(9):10-9. PubMed ID: 3002008
[TBL] [Abstract][Full Text] [Related]
8. Virus content and effectiveness of foot-and-mouth disease vaccines.
Czelleng F; Sólyom F
Acta Microbiol Acad Sci Hung; 1976; 23(1):77-81. PubMed ID: 180758
[TBL] [Abstract][Full Text] [Related]
9. [The effectiveness of foot-and-mouth disease vaccines in Switzerland. II. Stability problems].
Ackermann M; Müller HK; Bruckner L; Kihm U
Schweiz Arch Tierheilkd; 1989; 131(7):389-95. PubMed ID: 2552580
[TBL] [Abstract][Full Text] [Related]
10. [Possibilities of biophysicochemical antigen control in vaccine production using foot-and-mouth disease virus as an example (review)].
Liebermann H; Kwasniowski W; Strebelow G
Arch Exp Veterinarmed; 1988 Mar; 42(2):165-73. PubMed ID: 2840042
[No Abstract] [Full Text] [Related]
11. [Testing the activity of anti-foot-and-mouth disease vaccine in cattle: quantitative methods of antigenic extinction].
Terré J; Stellmann C; Brun A; Favre H; Fontaine J
Dev Biol Stand; 1976; 35():357-67. PubMed ID: 198306
[TBL] [Abstract][Full Text] [Related]
12. [Verification of a method of standardization of the antigens of anti-aphthous vaccine based on complement fixation capacity].
Strobbe R; Debecq J; Leunen J
Bull Off Int Epizoot; 1969; 71(3-4):397-404. PubMed ID: 4323528
[No Abstract] [Full Text] [Related]
13. Detection of foot-and-mouth disease antigen in bovine epithelial samples: comparison of sites of sample collection by an enzyme linked immunosorbent assay (ELISA) and complement fixation test.
Oliver RE; Donaldson AI; Gibson CF; Roeder PL; Le Blanc Smith PM; Hamblin C
Res Vet Sci; 1988 May; 44(3):315-9. PubMed ID: 2841733
[TBL] [Abstract][Full Text] [Related]
14. The use of suspension cultures for FMD vaccine production. Criteria for the evaluation of cells, virus and vaccine.
Nardelli L; Panina GF
Dev Biol Stand; 1976; 35():9-25. PubMed ID: 198318
[TBL] [Abstract][Full Text] [Related]
15. The use of serum neutralizing antibody assay for the determination of the potency of foot and mouth disease (FMD) vaccines in cattle.
Pay TW; Hingley PJ
Dev Biol Stand; 1986; 64():153-61. PubMed ID: 3025036
[TBL] [Abstract][Full Text] [Related]
16. A micro-enzyme-lavelled immunosorbent assay (MICORELISA) for the detection of foot-and-mouth disease virus antigen and antibody.
Rai A; Lahiri DK
Acta Virol; 1981 Jan; 25(1):49-52. PubMed ID: 6112866
[TBL] [Abstract][Full Text] [Related]
17. [Complement fixation micromethod for determining the type of foot-and-mouth disease virus].
Gritsenko AI; Sobko AI; Chepurkina AI
Veterinariia; 1975 Jan; (1):99-100. PubMed ID: 163522
[No Abstract] [Full Text] [Related]
18. [Preliminary study of the combination of anti-foot-and-mouth disease and anti-brucellosis vaccines].
Mastan MB; Amighi M; Ardelan A; Bandpay MR; Ebadi A; Farsi J
Dev Biol Stand; 1976; 35():437-43. PubMed ID: 198311
[TBL] [Abstract][Full Text] [Related]
19. Reduction of animal usage in the control of foot-and-mouth disease vaccines.
Strobbe R
Dev Biol Stand; 1986; 64():163-7. PubMed ID: 3025037
[TBL] [Abstract][Full Text] [Related]
20. [Demonstration of antibody-synthesizing cells in mice and swine by means of local hemolysis in gel following immunization with foot-and-mouth disease virus and vaccine].
Wittmann G; Reda I
Zentralbl Bakteriol Orig A; 1974; 227(1-4):420-5. PubMed ID: 4154623
[No Abstract] [Full Text] [Related]
[Next] [New Search]
